EL-22 in Animals: Fusion Protein of Myo-2 for Use in Encouraging Muscle Growth in Animals (Patent Application No. 19/191,246) ...

EL-22 in Animals: Fusion Protein of Myo-2 for Use in Encouraging Muscle Growth in Animals (Patent Application No. 19/191,246) ...

InVitria launches Optibumin® 25, the first recombinant 25% rHSA for closed-system use, enabling safer, scalable biomanufacturing.

The NASCAR Cup Series returns from a week's break to the madhouse known as Talladega Superspeedway for the Jack Link's 500 race on April 27. Talladega is a great opportunity for a midpack team to win ...

At the NI Connect conference, Emerson announced hardware and software enhancements to its portfolio that address the growing ...

China’s elite send their children to the United States to attend university. America’s publicly supported institutions then ...

Tesla’s AI-driven vision system, rising energy revenues, and misleadingly high P/E make the current valuation compelling. See ...

Blood-sucking ticks are gross and can carry a variety of diseases. But how do you protect yourself against ticks? And why do ...

DELRAY BEACH, FL / ACCESS Newswire / April 23, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company") is developing ...

Q3 2025 Earnings Conference Call April 29, 2025 10:00 AM ETCompany ParticipantsKevin Kim - VP, IRKevin Hourican - Chairman ...

Q1 2025 Earnings Call Transcript April 24, 2025 FARO Technologies, Inc. beats earnings expectations. Reported EPS is $0.33, ...

Trump’s current drive for lower interest rates and more easy money is doing little or nothing to help the working-class and ...